Walleye Capital LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 195 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$133,230
-40.2%
75,699
+6.6%
0.00%
-50.0%
Q4 2022$222,959
-53.1%
71,006
-26.9%
0.00%
-55.6%
Q3 2022$475,000
+446.0%
97,115
+361.0%
0.01%
+350.0%
Q2 2022$87,000
-82.2%
21,068
-74.9%
0.00%
-84.6%
Q1 2022$488,000
+373.8%
83,973
+632.4%
0.01%
+333.3%
Q3 2021$103,000
-75.3%
11,465
-57.1%
0.00%
-89.3%
Q4 2020$417,000
-70.9%
26,700
-80.0%
0.03%
-82.3%
Q2 2019$1,434,000
+52.1%
133,199
+34.8%
0.16%
+1.9%
Q1 2019$943,00098,8000.16%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders